4-Chloropyrido[3,4-d]pyrimidine
≥95%
- Product Code: 161941
CAS:
51752-67-1
Molecular Weight: | 165.58 g./mol | Molecular Formula: | C₇H₄ClN₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD09999184 | |
Melting Point: | Boiling Point: | 316.1°C at 760 mmHg | |
Density: | Storage Condition: | 2-8°C, stored in inert gas |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to mimic purine bases, enabling interaction with biological targets involved in cell signaling pathways. Its structure is often modified to enhance binding affinity and selectivity in drug candidates targeting tyrosine kinases and other enzymes in oncology and inflammatory diseases.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿1,440.00 |
+
-
|
250mg | 10-20 days | ฿3,550.00 |
+
-
|
1g | 10-20 days | ฿12,580.00 |
+
-
|
5g | 10-20 days | ฿39,560.00 |
+
-
|
4-Chloropyrido[3,4-d]pyrimidine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to mimic purine bases, enabling interaction with biological targets involved in cell signaling pathways. Its structure is often modified to enhance binding affinity and selectivity in drug candidates targeting tyrosine kinases and other enzymes in oncology and inflammatory diseases.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :